Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,650 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Follow-Up Questions
What is Omnicell Inc (OMCL)'s P/E Ratio?
The P/E ratio of Omnicell Inc is 107.0553
Who is the CEO of Omnicell Inc?
Mr. Randall Lipps is the Chairman of the Board of Omnicell Inc, joining the firm since 1992.
What is the price performance of OMCL stock?
The current price of OMCL is $35.06, it has increased 1.63% in the last trading day.
What are the primary business themes or industries for Omnicell Inc?
Omnicell Inc belongs to Health Care industry and the sector is Health Care
What is Omnicell Inc market cap?
Omnicell Inc's current market cap is $1.6B
Is Omnicell Inc a buy, sell, or hold?
According to wall street analysts, 8 analysts have made analyst ratings for Omnicell Inc, including 2 strong buy, 8 buy, 4 hold, 0 sell, and 2 strong sell
